Traders Agency Team
Editorial Team
The Traders Agency editorial team delivers daily market analysis, stock research, and trading education. Our team of analysts covers stocks, options, crypto, commodities, and macroeconomics to help traders make informed decisions.
French Bonds and Paris Stocks Slide After Worst Unrest in Years, a Day Before Budget Vote
French bonds and Paris stocks fell after violent weekend protests, with the 10-year yield at 4.89% per The Guardian and the OAT-Bund spread at its widest since the euro crisis per CNBC, ahead of Tuesday's budget vote.
Stock Market Today: Energy Leads While S&P 500 Slips
Energy led the session while the S&P 500 slips. See the validated market scorecard, sector performance, and what traders are watching next.
Travelers' Q3 2026 Core EPS of $9.18 Tops Consensus by $1.75 as Record Investment Income and 86.8% Combined Ratio Drive Beat
Travelers reported Q3 2026 core income of $1.95 billion, or $9.18 per diluted share, versus a $7.43 consensus, with record net investment income, an 86.8% combined ratio and $538 million of pre-tax catastrophe losses; shares rose after the report.
You Don’t Need to Make Money This Way
Waiting for a losing stock to return to your purchase price can keep money tied up in a trade you wouldn’t make today. Reassess the setup before making breakeven your exit plan.
Options Strategy Selection: How to Pick the Right Trade
Learn how to choose options strategy using direction, volatility, risk, and capital—so you stop guessing and start trading with a plan.
Tesla Unveils Thruster-Equipped Next-Generation Roadster at SpaceX Site, Targets 2028 Production With No Price Set
Tesla unveiled a thruster-equipped next-generation Roadster at a SpaceX test site in Texas, targeting 2028 production. No retail price was disclosed, street-legal status is unresolved, and analysts say the car is unlikely to move Tesla's financials.
Labcorp to Acquire BioReference Health Clinical, Women's Health and Urology Testing Assets From OPKO for $722 Million
Labcorp has agreed to acquire BioReference Health's clinical, women's health, urology and corrections testing assets from OPKO Health for $722 million in cash plus up to $150 million tied to 4Kscore revenue, pending regulatory approval.
CMA Proposes Designating Microsoft With Strategic Market Status in UK Business Software
The CMA has provisionally found Microsoft meets the statutory conditions for strategic market status in its UK business software ecosystem, covering Windows, Microsoft 365, Copilot, security and server products, with consultation responses due 13 November 2026 and a final decision by 13 February 2027.
Why Most YOLO Plays Fail: Position Sizing and Risk Management
Why YOLO plays fail: learn position sizing and risk management, the 1% rule, and how to calculate position size before your next trade.
Some Anthropic Investors Push for $1.5 Trillion IPO Valuation as Q3 Revenue Growth Cools to 45%
Some Anthropic investors are weighing a roughly $1.5 trillion IPO valuation, down from the $2 trillion previously floated, after the AI company disclosed Q3 revenue growth of 45% sequentially to $16.8 billion, Reuters reported.
CHMP Recommends EU Approval of Lilly's Oral GLP-1 Pill Foundayo for Obesity and Type 2 Diabetes
EMA's CHMP has recommended EU marketing authorisation for Eli Lilly's oral GLP-1 pill Foundayo (orforglipron) for weight management and type 2 diabetes, pending a European Commission decision.
MSCI Proposal to Strip Indonesia of Emerging-Market Status Triggers Jakarta's Worst Stock Drop Since 1998
MSCI's proposal to reclassify Indonesia as a standalone market triggered the steepest one-day Jakarta stock drop since 1998, with brokers estimating billions in potential outflows as regulators and the central bank moved to steady markets.
Stop watching.
Start winning.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.
